Skye Bioscience's total assets for Q were $15.60M, an increase of 597.89% from the previous quarter. SKYE total liabilities were $13.91M for the fiscal quarter, a 38.74% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.